AANS Neurosurgeon | Volume 26, Number 1, 2017


Regulation of Parkinson's Disease Inflammatory Responses by a MicroRNA

Bookmark and Share

According to a University of Alabama at Birmingham (UAB) study, a small regulatory RNA called microRNA-155 appears to play a key role in brain inflammation that is associated with Parkinson’s disease. Using a mouse model, researchers found microRNA-155 is both a potential therapeutic target and biomarker for Parkinson’s disease. Parkinson’s disease affects as many as 1 million Americans, even more than multiple sclerosis, muscular dystrophy and Lou Gehrig’s disease combined. Thousands of cases are not diagnosed and go undetected. Parkinson’s disease can progress for years while going undetected. The UAB researchers, led by David Standaert, MD, PhD, professor and chair of the UAB Department of Neurology, write that their results “suggest that microRNA-155 is involved early in Parkinson’s disease pathogenesis and is important for initiating the inflammatory response to alpha-synuclein.” Click here to read more. 


Microsurgery Course Zurich
March 29-April 1, 2017; Zurich, Switzerland

12th World Congress on Brain Injury
March 29-April 1, 2017; New Orleans

2017 National Neuroscience Review
March 31-April 1, 2017; National Harbor, Md.

Brain & Brain PET 2017
April 1-4, 2017; Berlin, Germany

Neurosurgical Society of America Annual Meeting 2017
April 2-5, 2017; Jacksonville, Fla.

Interactive Calendar

Comments are closed.

Email Spike Discount | March 25, 2016 at 2:00 am

In a special perspective, if your online business depends on the
Web to determine enterprise contacts world wjde and the
Website online crashes,the restoration effort becomes unimaginable as
a result of the knowledge was never retained within the first